Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An abnormal growth of the cells that comprise the tissues of the brainstem. While the tumor may be histologically benign, it can produce great morbidity due to its location. It presents most commonly in the first two decades of life.
Biomarker and diagnostic research for childhood brain stem glioma has been reported in the published literature.
2 clinical trials registered, 2 recruiting. Interventions under study include other interventions and medical devices. Pipeline includes 1 PHASE1. Research is primarily sponsored by academic and government institutions.
61 publications have been identified in PubMed for childhood brain stem glioma. Research spans Basic Science / Preclinical (49%), Epidemiology / Natural History (15%), and Review / Meta-Analysis (11%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 30 |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 1:14 PM UTC
Genetic and Rare Diseases Info Center
Disease patterns and progression | 9 | 15% |
Research summaries | 7 | 11% |
Clinical study results | 5 | 8% |
New treatment approaches | 5 | 8% |
Testing and diagnosis research | 3 | 5% |
Patient case studies | 2 | 3% |
Umaru B (2026). [PMID: 41455108](https://pubmed.ncbi.nlm.nih.gov/41455108/). *FEBS Open Bio*. [Basic Science / Preclinical]
Rahim AA (2026). [PMID: 41389437](https://pubmed.ncbi.nlm.nih.gov/41389437/). *Pharmacological reviews*. [Gene Therapy / Novel Therapeutics]
Cooper E (2026). [PMID: 41634415](https://pubmed.ncbi.nlm.nih.gov/41634415/). *Nature genetics*. [Review / Meta-Analysis]
Hongo H (2026). [PMID: 41454800](https://pubmed.ncbi.nlm.nih.gov/41454800/). *Pediatric blood & cancer*. [Gene Therapy / Novel Therapeutics]
Rrapaj E (2026). [PMID: 41620461](https://pubmed.ncbi.nlm.nih.gov/41620461/). *Cell death & disease*. [Basic Science / Preclinical]
Sill M (2026). [PMID: 41349541](https://pubmed.ncbi.nlm.nih.gov/41349541/). *Cancer cell*. [Diagnostic / Biomarker]
Mackall C (2026). [PMID: 41545304](https://pubmed.ncbi.nlm.nih.gov/41545304/). *Journal for immunotherapy of cancer*. [Basic Science / Preclinical]
Lindsay H (2026). [PMID: 41683962](https://pubmed.ncbi.nlm.nih.gov/41683962/). *International journal of molecular sciences*. [Basic Science / Preclinical]
Bernardi F (2026). [PMID: 41544627](https://pubmed.ncbi.nlm.nih.gov/41544627/). *Cancer cell*. [Basic Science / Preclinical]
Kardian AS (2026). [PMID: 41882368](https://pubmed.ncbi.nlm.nih.gov/41882368/). *Nature*. [Basic Science / Preclinical]